ArticleJAAD case reports2020
Successful treatment of refractory folliculitis decalvans with apremilast.
Article in JAAD case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review.PloS one · 2024Pooled it
- Sycosis Barbae Treated With Bimekizumab.The Australasian journal of dermatology · 2025Article
- PDE4 Inhibitor-Responsive Dermatoses: An Emerging Concept in Dermatology.The Journal of clinical and aesthetic dermatology · 2025Review
- Treatment Survival and Reasons for Discontinuation in Patients with Recalcitrant Folliculitis Decalvans.Acta dermato-venereologica · 2025Article
- Expanding therapeutic horizons: apremilast for refractory inflammatory dermatological conditions.Archives of dermatological research · 2025Article
- Response to Dethier et al, "Experience in nine additional cases of apremilast for therapy-resistant folliculitis decalvans".JAAD case reports · 2025Article
- Response to Fässler et al's "Successful treatment of refractory folliculitis decalvans with apremilast".JAAD case reports · 2025Article
- Refractory Folliculitis Decalvans: New Therapeutic Horizons?International journal of trichologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.